Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer

Oncogene

Volumn 24, Issue 44, 2005, Pages 6667-6675

  Röpke, Albrecht ^a   Buhtz, Peter ^a   Böhm, Malte ^a   Seger, Jeannette ^a   Wieland, Ilse ^a   Allhoff, Ernst P ^a   Wieacker, Peter F ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

DICE1 (DDX26); Downregulation; Hypermethylation; Promoter; Prostate cancer

Indexed keywords

AZACITIDINE; PROTEIN DICE1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA POLYMORPHISM; DOWN REGULATION; GENE ACTIVITY; GENE DELETION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; TUMOR CELL; UPREGULATION;

BASE SEQUENCE; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; DOWN-REGULATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RIBOSOMAL PROTEINS; RNA HELICASES; TUMOR SUPPRESSOR PROTEINS;

EID: 27144519672     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208824     Document Type: Article

References (35)

1. Ausubel F (ed) (1989). Current Protocols in Molecular Biology Vol. 2. Unit 12.2. John Wiley & Sons: New York, Chichester, Brisbane, Toronto, Singapore.
2. Bird A. (2002). Genes Dev., 16, 6-21.
3. Böhm M, Schmidt C, Wieland I, Leclerc N and Allhoff EP. (1999). Onkologie, 22, 296-301.
4. Böhm M, Wieland I, Schütze K and Rübben H. (1997). Am. J. Pathol., 151, 63-67.
5. Deng G, Chen A, Pong E and Kim YS. (2001). Oncogene, 20, 7120-7127.
6. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J and Weissenbach J. (1996). Nature, 380, 152-154.
7. DiNardo DN, Butcher DT, Robinson DP, Archer TK and Rodenhiser DI. (2001). Oncogene, 20, 5331-5340.
8. Esteller M and Herman JG. (2002). J. Pathol., 196, 1-7.
9. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL and Paul CL. (1992). Proc. Natl. Acad. Sci. USA, 89, 1827-1831.
10. Gardiner-Garden M and Frommer M. (1987). J. Mol. Biol., 196, 261-282.
11. Gibas Z, Becher R, Kawinski E, Horoszewicz J and Sandberg AA. (1984). Cancer Genet. Cytogenet., 11, 399-404.
12. Gleason DF, Nellinger GT and Veterans Administrative Cooperative Urological Research Group. (1974). J. Urol., 111, 58-64.
13. Gluzman Y. (1981). Cell, 23, 175-182.
14. Jones PA and Baylin SB. (2002). Nat. Rev. Genet., 3, 415-428.
15. Juttermann R, Li E and Jaenisch R. (1994). Proc. Natl. Acad. Sci. USA, 91, 11797-11801.
16. Klein G. (2002). Semin. Cancer Biol., 12, 327-330.
17. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M and Croce CM. (2003). Cancer Res., 63, 3724-3728.
18. Li WJ, Hu N, Su H, Wang C, Goldstein AM, Wang Y, Emmert-Buck MR, Roth MJ, Guo WJ and Taylor PR. (2003). Oncogene, 22, 314-318.
19. Livak KJ and Schmittgen TW. (2001). Methods, 25, 402-408.
20. Ogawara K, Miyakawa A, Shiba M, Uzawa K, Watanabe T, Wang XL, Sato T, Kubosawa H, Kondo Y and Tanzawa H. (1998). Int. J. Cancer, 79, 312-317.
21. Rehfuss RP, Walton KM, Loriaux MM and Goodman RH. (1991). J. Biol. Chem., 266, 18431-18434.
22. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D and DePinho RA. (1996). Cell, 85, 27-37.
23. Sobin LH and Wittekind CH. (1997). Classification of malignant tomours, 5th ed. Wiley-Liss: New York, pp 170-173.
24. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF. (1978). Int. J. Cancer, 21, 274-281.
25. Strathdee G. (2002). Semin. Cancer Biol., 12, 373-379.
26. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF and Sekiya T. (1997). Int. J. Cancer, 74, 45-49.
27. Ueda T, Emi M, Suzuki H, Komiya A, Akakura K, Ichikawa T, Watanabe M, Shiraishi T, Masai M, Igarashi T and Ito H. (1999). Genes, Chromsomes Cancer, 24, 183-190.
28. Watanabe T, Yokoo H, Yokoo M, Yonekawa Y, Kleihues P and Ohgaki H. (2001). J. Neuropathol. Exp. Neurol., 60, 1181-1189.
29. Wieland I, Arden KC, Michels D, Klein-Hitpass L, Böhm M, Viars CS and Weidle UH. (1999). Oncogene, 18, 4530-4537.
30. Wieland I, Röpke A, Stumm M, Sell C, Weidle UH and Wieacker PF. (2001). Oncol. Res., 12, 491-500.
31. Wieland I, Sell C, Weidle UH and Wieacker P. (2004). Oncol. Rep., 12, 207-211.
32. Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, Allinen M, Elkahloun A, Monni O, Chen Y, Kallioniemi A and Kallioniemi OP. (2004). Neoplasia, 6, 240-247.
33. Yang Q, Nakamura M, Nakamura Y, Yoshimura G, Suzuma T, Umemura T, Shimizu Y, Mori I, Sakurai T and Kakudo K. (2002). Clin. Cancer Res., 8, 2890-2893.
34. Yin Z, Spitz MR, Babaian RJ, Strom SS, Troncoso P and Kagan J. (1999). Oncogene, 18, 7576-7583.
35. Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF and Minna JD. (2001). Cancer Res., 61, 3581-3585.